Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



The role of Nrf2/SIRT1 pathway in the hepatoprotective effect of PEITC against HFD/STZ-induced diabetic liver disease. Short title: PEITC ameliorates liver injury via Nrf2/SIRT1 pathways

Buğrahan Atıcı, Ayşe Burçin Uyumlu, Aslı Taşlıdere.




Abstract
Cited by 0 Articles

Aim: We intended to assess the hepatoprotective effects of phenethyl isothiocyanate (PEITC) against oxidative liver injury induced by a high-fat diet (HFD) and streptozotocin (STZ) diabetes through the Nuclear Factor E2-Related Factor 2 (Nrf2) and Sirtuin 1 (SIRT1) pathways in rats.
Materials and Methods: Thirty male Wistar Albino rats were separated into three groups: the control group, the second group (HFD+STZ) fed HFD and injected with STZ (35mg/kg b.w.), and the third group (HFD+ STZ+PEITC) fed an HFD, injected with STZ (35mg/kg b.w.), and given PEITC (40mg/kg b.w. by oral gavage). Feeding with HFD and PEITC was given for two weeks and continued one more week following STZ. Serum ALT and lipids levels, antioxidant enzyme activities, MDA, GST, SIRT1, NF-ƙβ, and Nrf2 levels were measured. Liver histological changes were detected.
Results: In comparison with the control group, in the HFD+STZ group, serum HDL levels, activities of hepatic antioxidant enzymes, Nrf2 activity, levels of GST, SIRT1, and NF-ƙβ reduced and besides, serum ALT, TG, TC, LDL / VLDL, and hepatic MDA levels increased (p

Key words: Phenethyl isothiocyanate; Nuclear Factor E2-Related Factor 2; Sirtuin 1; liver injury






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.